Molecular basis of ACE2 inhibition by the peptide DX600 revealed by computational and biophysical analysis
Protein Science · 2026-12 · 35 (12)
DOI: 10.1002/pro.70866 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, online erschienen am 09.11.2026. Verfasst von Alessandro Mossa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Nanoscienze - CNR, S3, Modena, Italy. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, Imidazoles, Angiotensin-Converting Enzyme Inhibitors, Peptides. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministero dell'Università e della Ricerca.
Abstract (Originalsprache)
This study investigates the molecular mechanism of Angiotensin‐Converting Enzyme 2 (ACE2) inhibition by the peptide DX600 using an integrated computational and biophysical approach. Small molecules and peptides have been explored as ACE2 antagonists, including MLN‐4760 and the peptide DX600, but the molecular determinants underlying their inhibitory mechanisms remain incompletely understood. MLN‐4760 is known to interact within the catalytic cleft of ACE2 thereby inducing structural changes in ACE2 causing the receptor to undergo a transition from opened to closed conformation. On the contrary, our molecular dynamics simulations reveal that DX600 binding stabilizes the receptor, dampening fluctuations of key residues such as to lock the receptor in an open conformation. This stabilization produces a more rigid ACE2 structure, consistent with steric hindrance that may impede viral protein, for example, the SARS‐CoV‐2 spike protein, engagement. RMSF analysis, which quantifies local structural fluctuations at the residue level, confirms that DX600 reduces local residue mobility, highlighting a distinct mechanism from small‐molecule inhibitors. These results provide a detailed molecular picture of peptide‐mediated ACE2 inhibition and offer insights for the rational design of ACE2‐targeted small molecule therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Istituto Nanoscienze - CNR, S3, Modena, Italy.
- Istituto Nanoscienze - CNR, NEST-SNS, Pisa, Italy.
- Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.
- Department of Microbial Pathogenesis, University of Maryland Baltimore School of Dentistry, Baltimore, Maryland, USA.
- Department of Microbiology and Immunology, University of Maryland Baltimore School of Medicine, Baltimore, Maryland, USA.
- Department of Molecular Medicine, University of Padua, Padova, Italy.
ORCID-Profile: Alessandro Mossa, Salvatore Pacifico, Valentina Albanese, Alfredo Garzino Demo, Roberto Perris, Silvia Rossi, Valentina Tozzini, Giorgia Brancolini, Antonella Sgarbossa
Förderung
- Ministero dell'Università e della Ricerca
Zitieren
APA
Mossa, A., Papalini, A., Pacifico, S., Albanese, V., Demo, A. G., Perris, R., Rossi, S., Tozzini, V., Brancolini, G., & Sgarbossa, A. (2026). Molecular basis of ACE2 inhibition by the peptide DX600 revealed by computational and biophysical analysis. Protein Science, 35(12). https://doi.org/10.1002/pro.70866
Vancouver
Mossa A, Papalini A, Pacifico S, Albanese V, Demo AG, Perris R, et al. Molecular basis of ACE2 inhibition by the peptide DX600 revealed by computational and biophysical analysis. Protein Science. 2026;35(12). doi:10.1002/pro.70866
BibTeX
@article{Mossa2026,
author = {Mossa, Alessandro and Papalini, Alessia and Pacifico, Salvatore and Albanese, Valentina and Demo, Alfredo Garzino and Perris, Roberto and Rossi, Silvia and Tozzini, Valentina and Brancolini, Giorgia and Sgarbossa, Antonella},
title = {Molecular basis of ACE2 inhibition by the peptide DX600 revealed by computational and biophysical analysis},
journal = {Protein Science},
year = {2026},
volume = {35},
number = {12},
doi = {10.1002/pro.70866}
}
EUVIMED